Himanshu Agarwal

Cohance :About Us :Leadership :Himanshu Agarwal
Cohance : About Us : Leadership : Himanshu Agarwal

Executive Leadership Team

Himanshu Agarwal

Chief Financial Officer
himanshu-agarwal

Himanshu Agarwal

Chief Financial Officer

Appointed: 2 January 2024

Mr. Himanshu Agarwal is the Chief Financial Officer of the Company and oversees Finance, IT, Legal, Secretarial, and Investor Relations.

He brings 29 years of professional experience, having held senior roles at ICI India, AstraZeneca Pharma, Akzo Nobel India, Huhtamaki Oyj, and Bennett, Coleman & Co. Ltd. Himanshu’s deep expertise spans finance, M&A, investor relations, business strategy, and technology enablement across sectors including pharmaceuticals, packaging, media, chemicals, and coatings.

A rank-holder Chartered Accountant, Company Secretary, and Cost and Management Accountant, Himanshu has led numerous strategic initiatives including finance transformation, profit turnaround, value chain optimization, and M&A integrations. He has also enabled enterprise-wide technology adoption—from ERP systems to BOTs—and was awarded ‘Best CFO’ by the Institute of Chartered Accountants of India.

Dr. V. Prasada Raju was appointed Managing Director of Suven Pharmaceuticals on September 29, 2023. He also serves as the CEO and Managing Director of Cohance Lifesciences Ltd.Dr. Raju brings over three decades of comprehensive experience in the pharmaceutical industry, with strong credentials in strategy, operations, scientific affairs, and business development. Previously, he was Executive Director at Granules India Ltd, where he played a pivotal role in shaping growth strategy, managing the product pipeline, leading regulatory and intellectual property functions, and spearheading new business initiatives. He was also instrumental in setting up R&D and Greenfield manufacturing projects.
In his earlier roles, Dr. Raju served on the boards of several key entities, including Granules Omnichem Pvt. Ltd. (Vizag, India), Granules Pharmaceuticals Inc. (Washington, D.C., USA), and USpharma Ltd. (Florida, USA). He spent nearly two decades at Dr. Reddy’s Laboratories (1994–2012), holding senior positions with responsibilities spanning technical, strategic, and operational leadership. Dr. Raju holds a PhD in Chemistry and a Postgraduate Diploma in Patent Law, and has undergone specialized training in material sciences at IIT, Chicago, USA. He is also an alumnus of the Senior Management Program at the Indian Institute of Management, Calcutta (IIMC). Dr. Raju’s diverse expertise and leadership acumen position him as a highly respected figure in the pharmaceutical sector. Other Directorships / Full-time Positions in Body Corporates:
Name of the Company / Body Corporate
Cohance Lifesciences Limited
Position
Managing Director
Name of the Company / Body Corporate
Sapala Organics Private Limited
Position
Director
In his earlier roles, Dr. Raju served on the boards of several key entities, including Granules Omnichem Pvt. Ltd. (Vizag, India), Granules Pharmaceuticals Inc. (Washington, D.C., USA), and USpharma Ltd. (Florida, USA). He spent nearly two decades at Dr. Reddy’s Laboratories (1994–2012), holding senior positions with responsibilities spanning technical, strategic, and operational leadership. Dr. Raju holds a PhD in Chemistry and a Postgraduate Diploma in Patent Law, and has undergone specialized training in material sciences at IIT, Chicago, USA. He is also an alumnus of the Senior Management Program at the Indian Institute of Management, Calcutta (IIMC). Dr. Raju’s diverse expertise and leadership acumen position him as a highly respected figure in the pharmaceutical sector. Other Directorships / Full-time Positions in Body Corporates:
SI Name of the Company / Body Corporate Position
1 Cohance Lifesciences Limited Managing Director
2 Sapala Organics Private Limited Director